Latest News

 Filter by Provider

It might be an old company, but it is generating excitement from investors.

DexCom (DXCM) offers affordable growth with strong expansion, solid profitability, and a reasonable valuation in the diabetes care market.

Like most other investors, it's taken me a while to fully embrace everything the Oracle of Omaha has been saying for a long time.

The crypto sector has slowed down lately.

There will soon be a new quantum computing kid on the block.

The US dollar pulls lower as the Swiss franc looks to regain its footing.

The price has reached a naturally bullish recent inflection zone, but is likely to decline to at least $0.6500 if risk sentiment continues to deteriorate today.

Which of these Chinese tech giants is a better investment right now?

Michael Burry is doubling down on his AI bubble claims, as his short position backfires following the rally in key stocks early this week.

Artificial intelligence is likely to be a dominant theme in the stock market again in 2026, and this beneficiary of the trend looks undervalued.

Autodesk (ADSK) offers strong growth, top-tier profitability, and a reasonable valuation for investors seeking affordable growth stocks in the software sector.

Pharma distributor Cencora has continued to outpace the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

The Vanguard 500 ETF remains a great exchange-traded fund to invest in.

The US government shutdown looks likely to end in the coming days, with a House vote now the final hurdle.

There's a workaround you should know about.

Ball has significantly underperformed the broader market over the past year, yet analysts remain cautiously optimistic about the stock’s prospects.

Cryptocurrency is swiftly becoming a core part of investor portfolios, but which one is right for you?

Bad news from the University of Michigan's consumer sentiment survey just might be good news for investors.

BNY Mellon has observed a significant surge over the past year, outpacing the broader market. While analysts remain optimistic about the stock’s prospects, its mean-price target suggests a modest single-digit upside potential.

Elon Musk and Donald Trump clash on $38T debt solutions. Musk sees AI and robotics as the 'only way,' while Trump touts tariff revenue.

Bitcoin's rally is fading near key resistance as technical signals like a potential death cross and double-top pattern point to a likely pullback toward $100,000.

Insurance giant Progressive has notably underperformed the broader market over the past year, yet analysts remain cautiously optimistic about the stock’s prospects.

These healthcare heavyweights have tumbled, causing abnormally high dividend yields.

Railroad giant Union Pacific has notably underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.

Despite SoftBank’s Masayoshi Son envisaging a deeper plunge into AI, his firm exited its Nvidia position at the end of the September quarter.

Solaris Energy Infrastructure (SEI) stock shows a powerful technical uptrend and explosive fundamental growth, meeting strict criteria for momentum investors.

IonQ is generating meaningfully more revenue than most of its quantum computing peers.

The Palantir story looks bright, but one element has been hurting the stock.

Indian share markets are trading lower today, with the Sensex trading 197 points lower, and the Nifty is trading 57 points lower.

According to a Bloomberg News report, citing people familiar with the matter, several shareholders of Grab rival GoTo signed a memo to the board requesting an extraordinary general meeting.

Elliott’s stake in Toyota Industries has reportedly risen to nearly 5%, making it one of the company’s largest shareholders.

Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.

The U.S. dollar extended its retreat this week as weak labor data, political uncertainty, and a sell-off in AI stocks weighed on sentiment, though progress toward ending the record 40-day government shutdown offered some relief.

The company replaced its CEO last year, and the turnaround has been going well.

The company reported a net loss of $6.67 per share, while analysts expected it to post a loss of $3.24 per share, according to a Bloomberg News report.

The prospect of a quick end to the US government shutdown has rekindled investor confidence. Tech rebounds, semiconductors sprint ahead, and insurers feel political pressure building. Meanwhile, all eyes shift toward the last major earnings report of the season: Nvidia.

Uber is up more than 20% this past year, and it's still not getting enough love from investors.

Retirees should review how required minimum distributions (RMDs) are calculated as the year draws to a close.

Lennox International excels with strong revenue & profit growth, a stellar 37.65% ROIC, and a healthy balance sheet, making it a top quality investment candidate.

Galecto announced the acquisition of Damora Therapeutics and a $285 million private raise backed by major biotech investors, including Viking Global, RA Capital, and a16z Bio + Health.

Pfizer not only beat expectations last quarter, but also boosted its guidance.

Shares have tumbled in the wake of earnings, and there are other big risks for investors to consider with this growth stock.

Good news: You don't have to be a billionaire to invest like Buffett.

ODDITY Tech offers strong growth at a fair price. With high revenue growth, profitability, and a reasonable P/E ratio, it fits the 'affordable growth' investment strategy.

The company recently told its own story, putting AWS in the most bullish light. It left out a couple of important details.

Apple has reportedly secured over half of TSMC's 2nm chip capacity for 2026, tightening its lead in next-gen semiconductors.